Table 1.
Baseline demographics of the included patients (N = 367)
| ACRN group (N = 264) |
ASP group (N = 33) |
HRP group (N = 70) |
p value | |
|---|---|---|---|---|
| Age < 50 years | 51 (19%) | 15 (45%) | 15 (21%) | 0.006 |
| Male | 180 (68%) | 22 (67%) | 55 (79%) | 0.207 |
| Obesity | 101 (39%) | 10 (32%) | 32 (46%) | 0.353 |
| Visceral obesity | 36 (16%) | 3 (10%) | 13 (21%) | 0.449 |
| Comorbidity | ||||
| Hypertension | 77 (29%) | 4 (12%) | 28 (40%) | 0.012 |
| Diabetes | 37 (14%) | 0 | 16 (23%) | 0.004 |
| Dyslipidemia | 50 (19%) | 4 (12%) | 15 (21%) | 0.531 |
| Medications | ||||
| Aspirin | 25 (9%) | 0 | 11 (16%) | 0.030 |
| Statins | 34 (13%) | 3 (9%) | 13 (19%) | 0.361 |
| Metformin | 21 (8%) | 0 | 8 (11%) | 0.116 |
| Current smoker | 82 (31%) | 8 (25%) | 19 (27%) | 0.700 |
| Alcohol intake | 137 (52%) | 16 (49%) | 54 (77%) | < 0.001 |
| Family history of CRC | 27 (10%) | 4 (13%) | 7 (10%) | 0.883 |
ACRN advanced colorectal neoplasm, ASP advanced serrated polyps, HRP high-risk polyps, CRC colorectal cancer